The trade document shows that WUXI XDC Shareholder Hong Kong Hequan Pharmaceutical Co., Ltd. is seeking to sell up to HK$1.2 billion (US$0.153 billion) in shares. Selling 37.8 million shares at HK$30.855-31.515 per share, representing a discount of 4.5%-6.5% compared to WUXI XDC's closing price on Friday. The lock-up period for the seller is 90 days.
文件：药明合联股东将出售至多1.53亿美元股份
Document: WUXI XDC Shareholders will sell up to $0.153 billion in shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated